NCT04003181View on ClinicalTrials.gov

The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 28, 2017

Primary Completion Date

May 26, 2021

Study Completion Date

May 26, 2021

Conditions
Colon AdenocarcinomaDiarrhea
Interventions
DRUG

Antibiotics

Ciprofloxacin or Rifaximin for 10 days.

DRUG

Bile Acid Binder

Cholestyramine or Colesevelam lifelong.

Trial Locations (1)

8200

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

Danish Cancer Society

OTHER

collaborator

GE Healthcare

INDUSTRY

lead

University of Aarhus

OTHER